Neuronetics, Inc. Files 8-K Report
Ticker: STIM · Form: 8-K · Filed: Aug 12, 2024 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financials, operations
TL;DR
Neuronetics dropped an 8-K on 8/12 - check it for the latest financials and operational news.
AI Summary
On August 12, 2024, Neuronetics, Inc. filed an 8-K report detailing its financial results and other material information. The filing includes information on the company's operations, financial condition, and exhibits, as is standard for a current report.
Why It Matters
This filing provides investors with timely updates on Neuronetics, Inc.'s financial performance and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a standard 8-K filing reporting on financial results and operations, not indicating any immediate or unusual risks.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- August 12, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3222 Phoenixville Pike, Malvern, PA 19355 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Neuronetics, Inc.?
The primary purpose is to report on the Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits as of August 12, 2024.
When was the earliest event reported in this filing?
The earliest event reported is dated August 12, 2024.
In which state is Neuronetics, Inc. incorporated?
Neuronetics, Inc. is incorporated in Delaware.
What is the business address of Neuronetics, Inc.?
The business address is 3222 Phoenixville Pike, Malvern, PA 19355.
What is the SIC code for Neuronetics, Inc.?
The Standard Industrial Classification (SIC) code for Neuronetics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 2,027 words · 8 min read · ~7 pages · Grade level 15.8 · Accepted 2024-08-12 08:32:00
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M
Filing Documents
- d760452d8k.htm (8-K) — 37KB
- d760452dex991.htm (EX-99.1) — 138KB
- d760452dex992.htm (EX-99.2) — 40KB
- g760452g49e09.jpg (GRAPHIC) — 7KB
- 0001193125-24-198417.txt ( ) — 376KB
- stim-20240812.xsd (EX-101.SCH) — 3KB
- stim-20240812_lab.xml (EX-101.LAB) — 17KB
- stim-20240812_pre.xml (EX-101.PRE) — 11KB
- d760452d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated August 12, 2024 99.2 Press Release, dated August 12, 2024 104 Cover Page Interactive Data File (cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 12, 2024 NEURONETICS, INC. By: /s/ W. Andrew Macan W. Andrew Macan EVP, GC & Chief Compliance Officer